Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Seliger

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
International Journal of Cancer|March 17, 1999
Induction of immunogenicity of a human renal-cell carcinoma cell line by TAP1-gene transferM Kallfelz, D Jung, C Hilmes, et al.
European Journal of Immunology|March 4, 1998
Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblastsB Seliger, C Harders, S Lohmann, et al.
Cancer Research|September 29, 1998
Heterogeneous expression of the tumor-associated antigens RAGE-1, PRAME, and glycoprotein 75 in human renal cell carcinoma: candidates for T-cell-based immunotherapies?E Neumann, A Engelsberg, J Decker, et al.
Oncogene|May 12, 2009
Expression, regulation and function of the ISGylation system in prostate cancerA Kiessling, C Hogrefe, S Erb, et al.
International Journal of Cancer|July 18, 2000
HER-2/neu is expressed in human renal cell carcinoma at heterogeneous levels independently of tumor grading and staging and can be recognized by HLA-A2.1-restricted cytotoxic T lymphocytesB Seliger, Y Rongcun, D Atkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1996
Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expressionB Seliger, A Höhne, A Knuth, et al.
Clinical and Experimental Immunology|September 25, 2018
Blood immune cell biomarkers in lung cancerD Riemann, M Cwikowski, S Turzer, et al.
British Journal of Cancer|February 5, 2009
Overexpressed vs mutated Kras in murine fibroblasts: a molecular phenotyping studyM Horsch, C V Recktenwald, S Schädler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1997
IFN-gamma-mediated coordinated transcriptional regulation of the human TAP-1 and LMP-2 genes in human renal cell carcinomaB Seliger, S Hammers, A Höhne, et al.
Experimental Hematology|September 1, 1996
Suppression of MHC class I antigens in oncogenic transformants: association with decreased recognition by cytotoxic T lymphocytesB Seliger, C Harders, U Wollscheid, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
International Journal of Cancer|March 17, 1999
Induction of immunogenicity of a human renal-cell carcinoma cell line by TAP1-gene transferM Kallfelz, D Jung, C Hilmes, et al.
European Journal of Immunology|March 4, 1998
Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblastsB Seliger, C Harders, S Lohmann, et al.
Cancer Research|September 29, 1998
Heterogeneous expression of the tumor-associated antigens RAGE-1, PRAME, and glycoprotein 75 in human renal cell carcinoma: candidates for T-cell-based immunotherapies?E Neumann, A Engelsberg, J Decker, et al.
Oncogene|May 12, 2009
Expression, regulation and function of the ISGylation system in prostate cancerA Kiessling, C Hogrefe, S Erb, et al.
International Journal of Cancer|July 18, 2000
HER-2/neu is expressed in human renal cell carcinoma at heterogeneous levels independently of tumor grading and staging and can be recognized by HLA-A2.1-restricted cytotoxic T lymphocytesB Seliger, Y Rongcun, D Atkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1996
Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expressionB Seliger, A Höhne, A Knuth, et al.
Clinical and Experimental Immunology|September 25, 2018
Blood immune cell biomarkers in lung cancerD Riemann, M Cwikowski, S Turzer, et al.
British Journal of Cancer|February 5, 2009
Overexpressed vs mutated Kras in murine fibroblasts: a molecular phenotyping studyM Horsch, C V Recktenwald, S Schädler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1997
IFN-gamma-mediated coordinated transcriptional regulation of the human TAP-1 and LMP-2 genes in human renal cell carcinomaB Seliger, S Hammers, A Höhne, et al.
Experimental Hematology|September 1, 1996
Suppression of MHC class I antigens in oncogenic transformants: association with decreased recognition by cytotoxic T lymphocytesB Seliger, C Harders, U Wollscheid, et al.
Pageof 9